Atherosclerosis: Imaging techniques and the evolving role of nuclear medicine

Journal of Nuclear Medicine

Volumn 38, Issue 11, 1997, Pages 1788-1796

  Vallabhajosula, Shankar ^a   Fuster, Valentin ^b  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b NONE

Author keywords

Atherosclerosis; Atherothrombosis

Indexed keywords

FLUORODEOXYGLUCOSE F 18; MONOCLONAL ANTIBODY;

ANGIOGRAPHY; ANGIOSCOPY; ARTICLE; ATHEROSCLEROSIS; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; ECHOGRAPHY; HUMAN; IMAGE ANALYSIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; THROMBOSIS;

ARTERIOSCLEROSIS; DIAGNOSTIC IMAGING; HUMANS; NUCLEAR MEDICINE; RADIOPHARMACEUTICALS; THROMBOSIS;

EID: 0030698676     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (87)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-809.
2. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995;92:657-671.
3. Stary HC, Chandler AB, Dinsmore RE, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the committee on vascular lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb 1995;15:1512-1531.
4. Stary HC, Chandler AB, Glagov S, et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the committee on vascular lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb 1994;14:840-856.
5. Falk E, Fernandez-Ortiz A. Role of thrombosis in atherosclerosis and its complications. Am J Cardiol 1995;75:5B-11B.
6. Maximilian LB, Willerson JT. Role of inflammation in coronary plaque disruption. Circulation 1994;89:503-505.
7. Kaartnen M, Penttila A, Kovanen PT. Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture. Circulation 1994;90:1669-1678.
8. Fuster V, Lewis A. Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology. Circulation 1994;90:2126-2146.
9. Fuster V, Fallon JT, Nemerson Y. Coronary thrombosis. Lancet 1996;348:s7-s10.
10. Moreno PR, Falk E, Palacios IF, et al. Macrophage infiltration in acute coronary syndromes. Implications Plaque Rupture Circ 1994;90:775-778.
11. Galis ZS, Galina Sukhova GK, Kranzhofer R, et al. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc Natl Acad Sci USA 1995;92:402-406.
12. Ross R. Cell biology of atherosclerosis. Annu Rev Physiol 1995;57:791-804.
13. Ambrose JA. Angiographic correlations of advanced coronary lesions in acute coronary syndromes. In: Fuster V, ed. Syndromes of atherosclerosis: correlations of clinical imaging and pathology. Armonk, NY: Futura Publishing Company, Inc.; 1996:105-122.
14. Kohler TR. Imaging of carotid artery lesions: a surgeon's view. In: Fuster V, ed. Syndromes of atherosclerosis: correlations of clinical imaging and pathology. Armonk, NY: Futura Publishing Company, Inc.; 1996:205-223.
15. Dinsmore RE, Rivitz SM. Imaging techniques in carotid and peripheral vascular disease. In: Fuster V, ed. Syndromes of atherosclerosis: correlations of clinical imaging and pathology. Armonk, NY: Futura Publishing Company, Inc.; 1996:277-289.
16. den Heijer P, Foley DP, Hillege HL, et al. The "Erminonville" classification of observations at coronary angioscopy: evaluation of intra-and inter-observer agreement. Eur Heart J 1994;15:815-822.
17. Uchida Y, Nakamura F, Tomaru T, et al. Prediction of acute coronary syndromes by percutaneous coronary angioscopy in patients with stable angina. Am Heart J 1995;130:195-203.
18. Thieme T, Wernecke KD, Meyer R, et al. Angioscopic evaluation of atherosclerotic plaques. Validation by histomorphologic analysis and association with stable and unstable coronary syndromes. J Am Coll Cardiol 1996;28:1-6.
19. Feld S, Ganim M, Cavell ES, et al. Comparison of angioscopy, intra-vascular ultrasound imaging and quantitative coronary angiography in predicting clinical outcome after coronary intervention in high-risk patients. J Am Coll Cardiol 1996;28: 97-105.
20. Nissen SE, Tuzcu EM, DeFranco AC. Detection and quantification of atherosclerosis: the emerging role for intravascular ultrasound. In: Fuster V, ed. Syndromes of atherosclerosis: correlations of clinical imaging and pathology. Armonk, NY: Futura Publishing Company, Inc.; 1996:291-312.
21. Von Birgelen C, Slager CJ, Mario CD, et al. Intra-coronary ultrasound: a new maximum confidence approach for the quantitative assessment of progression-regression of atherosclerosis? Atherosclerosis 1995;118:S103-S113.
22. Roelandt JRTC, Di Mario C, Pandian NG, et al. Three-dimensional reconstruction of intracoronary ultrasound images: rationale, approaches, problems and directions. Circulation 1994;90:1044-1055.
23. Eliasziw M, Rankin MB, Fox AJ, et al. Accuracy and prognostic consequences of ultrasonography in identifying severe carotid stenosis. Stroke 1995;26:1747-1752.
24. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. J Am Med Assoc 1995;273:1421-1428.
25. Patel MR, Kuntz KM, Klufas RA, et al. Preoperative assessment of the carotid bifurcation. Can magnetic resonance angiography and duplex ultrasonography replace contrast arteriography? Stroke 1995;26:1753-1758.
26. Weinberger J, Ramos L, Ambrose JA, Fuster V. Morphologic and dynamic changes of atherosclerotic plaque at the carotid artery bifuration: sequential imaging by real-time B-mode ultrasonography. J Am Coll Cardiol 1988;12:1515-1521.
27. Hodis HN, Mack WJ, LaBree L, et al. Reduction of carotid wall thickness using lovastatin and dietary therapy. Ann Intern Med 1996;124:548-556.
28. Wexler L, Brundage B, Crouse J, et al. Coronary artery calcification: pathophysiology, epidemiology, imaging methods and clinical implications. Circulation 1996;94:1175-1192.
29. Agatston AS, Janowitz WR, Hildner FJ, et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990;15:827-832.
30. Brundage BH. The calcium story and electron beam computed tomography. In: Fuster V, ed. Syndromes of atherosclerosis: correlations of clinical imaging and pathology. Armonk, NY: Futura Publishing Company, Inc.; 1996:417-427.
31. Janowitz WR, Agatston AS, Kaplan G, Viamonte M Jr. Differences in prevalence and extent of coronary calcium detected by ultrafast computed tomography in asymptomatic men and women. Am J Cardiol 1993;72:247-254.
32. Doyle M, Pohost G. Magnetic resonance coronary artery imaging. In: Fuster V, ed. Syndromes of atherosclerosis: correlations of clinical imaging and pathology. Armonk, NY: Futura Publishing Company, Inc.: 1996:313-332.
33. Grist T, Turski PA. Nuclear magnetic resonance imaging as applied to carotid and peripheral atherosclerotic vascular disease. In: Fuster V, ed. Syndromes of atherosclerosis: correlations of clinical imaging and pathology. Armonk, NY: Futura Publishing Company, Inc.; 1996:333-362.
34. Pennell DJ, Bogren HG, Keegan J, et al. Assessment of coronary stenosis by magnetic resonance imaging. Heart 1996;75:127-133.
35. Yuan C, Tsuruda JS, Beach KN, et al. Techniques for high resolution MR imaging of atherosclerotic plaque. J Magn Reson Imaging 1994;4:43-49.
36. Maynor CH, Charles HC, Herfkens RJ, et al. Chemical shift imaging of atherosclerosis at 7.0 tesla. Invest Radiol 1989;24:52-60.
37. Skinner MP, Yuan C, Mitsumori L, et al. Serial MRI of experimental atherosclerosis detects lesion fine structure, progression and complications in vivo. Nat Med 1995;1:69-73.
38. 2-weighted contrast for NMR characterization of human atherosclerosis. Arterioscler Thromb 1995;15:1533-1542.
39. Toussaint JF, LaMuraglia GM, Southern JF, et al. Magnetic resonance images lipid, fibrous, calcified, hemorrhagic and thrombotic components of human atherosclerosis in vivo. Circulation 1996;94:932-938.
40. Sinzinger H, Virgolini I. Nuclear medicine and atherosclerosis. Eur J Nucl Med 1990;17:160-178.
41. Kritz H, Underwood SR, Sinzinger H. Imaging of atherosclerosis (part II). Wien Klin Wochenschr 1996;108:87-97.
42. Strauss WH. Imaging atherosclerosis: a worthy challenge. J Nucl Cardiol 1996;3:278-280.
43. Chang MY, Lees AM, Lees RS, et al. Time course of 125I-labeled LDL accumulation in the healing, balloon-deendothelialized rabbit aorta. Arterioscler Thromb 1992;12: 1088-1098.
44. Lees RS, Lees AM, Strauss HW. External imaging of human atherosclerosis. J Nucl Med 1983;24:154-156.
45. Vallabhajosula S, Paidi M, Badimon JJ. et al. Radiotracers for low density lipoprotein biodistribution studies in vivo: technetium-99m low density lipoprotein versus radioiodinated low density lipoprotein preparations. J Nucl Med 1988;29:1237-1245.
46. Rosen JM, Butler SP, Meinken GE, et al. Indium-111-labeled LDL: a potential agent for imaging atherosclerotic disease and lipoprotein distribution. J Nucl Med 1990;31: 343-350.
47. 99mTc-labeled low density lipoproteins. Atherosclerosis 1988;8:461-468.
48. Virgolini I, Rauscha F, Lupattelli G, et al. Autologous low-density lipoprotein labeling allows characterization of human atherosclerotic lesions in vivo as to presence of foam cells and endothelial coverage. Eur J Nucl Med 1991;18:948-951.
49. 99mTc-low density lipoprotein: intracellularly trapped radiotracer for non-invasive imaging of LDL metabolism in vivo. Semin Nucl Med 1990;20:68-79.
50. 99mtechnetium-labeled low density lipoprotein uptake by tendon xanthomas in hypercholesterolemic subjects. Arteriosclerosis 1990;10:256-262.
51. Pirich C, Sinzinger H. Evidence for lipid regression in humans in vivo performed by 123I-low-density lipoprotein scintiscanning. Ann NY Acad Sci 1995;748:613-621.
52. 99mtechnetium-labeled oxidized LDL in man. Atherosclerosis 1996;126:131-141.
53. Chang MY, Lees AM, Lees RS. Low density lipoprotein modification and arterial wall accumulation in a rabbit model of atherosclerosis. Biochemistry 1993;32:8518-8524.
54. Shih I-L, Lees RS, Chang MY, Lees AM. Focal accumulation of an apolipoprotein B-based synthetic oligopeptide in the healing rabbit arterial wall. Proc Natl Acad Sci USA 1990;87:1436-1440.
55. Hardoff R, Braegelmann F, Zanzanico P, et al. External imaging of atherosclerosis in rabbits using an 123I-labeled synthetic peptide fragment. J Clin Pharmacol 1993;33: 1039-1047.
56. Vallabhajosula S, Ali KSM, Goldsmith SJ, et al. Evaluation of Tc-99m-labeled peptides for imaging atherosclerotic lesions in vivo. J Nucl Med 1993;34:66P.
57. Lees RS, Lees AM. Radiopharmaceutical imaging of atherosclerosis. In: Fuster V, ed. Syndromes of atherosclerosis: correlations of clinical imaging and pathology. Armonk, NY: Futura Publishing Company, Inc.; 1996:385-401.
58. 125I-endothelin-1 accumulation in experimental arterial wall injury. Eur J Nucl Med 1993;20:1141-1145.
59. Dinkelborg LM, Hilger CS, Semmier W. Endothelin derivatives for imaging of atherosclerosis. J Nucl Med 1995;36:102P.
60. Fischman AJ, Rubin RH, Khaw BA, et al. Radionuclide imaging of experimental atherosclerosis with nonspecific polyclonal immunoglobulin G. J Nucl Med 1989;30: 1095-1100.
61. Sinzinger H, Rodrigues M, Kritz H. Radioisotopic imaging of atheroma. In: Fuster V, ed. Syndromes of atherosclerosis: correlations of clinical imaging and pathology. Armonk, NY: Futura Publishing Company, Inc.; 1996:369-383.
62. Demacker PNM, Dormans TPJ, Koenders EB, Corstens FHM. Evaluation of indium-111-polyclonal immunoglobulin G to quantitate atherosclerosis in Watanabe heritable hyperlipidemic rabbits with scintigraphy: effect of age and treatment with antioxidants or ethinylestradiol. J Nucl Med 1993;34:1316-1321.
63. Narula J, Petrov A, Bianchi C, et al. Noninvasive localization of experimental atherosclerotic lesions with mouse/human chimeric Z2D3 F(ab′)2 specific for the proliferating smooth muscle cells of human atheroma imaging with conventional and negative charge-modified antibody fragments. Circulation 1995;92:474-484.
64. 2 in the detection of atherosclerotic plaques [Abstract]. J Nucl Med 1995;36:133P.
65. 131I-Ama monoclonal antibody in atherosclerotic rabbits. Nucl Med Biol 1995;22: 693-697.
66. Loscalzo J, Rocco TP. Imaging arterial thrombi. An elusive goal. Circulation 1992;85:382-385.
67. Smyth JV, Dodd PDF, Walker MG. Indium-111 platelet scintigraphy in vascular disease. Br J Surg 1995;82:588-595.
68. Minar E, Ehringer H, Dudczak R, et al. Indium-111-labeled platelet scintigraphy in carotid atherosclerosis. Stroke 989;20:27-33.
69. Moriwaki H, Matsumoto M, Handa N, et al. Functional and anatomic evaluation of carotid atherosclerosis. A combined study of In-111 platelet scintigraphy and B-mode ultrasonography. Arterioscler Thromb 1995;15:2234-2240.
70. 123I-fibrinogen. Lancet 1978:242-244.
71. Uehara A, Isaka Y, Hashikawa K, et al. Iodine-131-labeled fibronectin: potential agent for imaging atherosclerotic lesion and thrombus. J Nucl Med 1988;29:1264-1267.
72. Knight LC. Scintigraphic methods for detecting vascular thrombus. J Nucl Med 1993;34:554-561.
73. Thiagarajan P, Tait JF. Binding of annexin V, placental anticoagulant protein I to platelets. Evidence for phosphatidylserine exposure in the procoagulant response of activated platelets. J Biol Chem 1990;265:17420-17423.
74. Stratton JR, Dewhurst TA, Kasina S, et al. Selective uptake of radiolabeled annexin V on acute porcine left atrial thrombi. Circulation 1995;92:3113-3121.
75. Miller DD. Radionuclide labeled monoclonal antibody imaging of atherosclerosis and vascular injury. In: Fuster V, ed. Syndromes of atherosclerosis: correlations of clinical imaging and pathology. Armonk, NY: Futura Publishing Company, Inc.; 1996:403-416.
76. Seabold JE, Rosebrough SF. Will a radiolabeled antibody replace In-111-platelets to detect active thrombus. J Nucl Med 1994;35:1738-1740.
77. Stratton JR, Cerqueira MD, Dewhurst TA, Kohler TR. Imaging arterial thrombosis in humans: comparison of technetium-99m-labeled monoclonal antifibrin antibodies and indium-111-labeled-platelets. J Nucl Med 1994;35:1731-1737.
78. Knight LC, Maurer AH, Romano JE, et al. Comparison of iodine-123-disintegrins for imaging thrombi and emboli in a canine model. J Nucl Med 1996;37:476-482.
79. Lister-James J, Knight LC, Maurer AH, et al. Thrombus imaging with a technetium-99m-labeled activated platelet receptor-binding peptide. J Nucl Med 1996;37:775-781.
80. Lister-James J, Vallabhajosula S, Moyer BR, et al. Thrombus imaging using technetium-99m-labeled, activated platelet receptor-binding peptides: pre-clinical evaluation of 99mTc-P748. J Nucl Med 1997;38:105-111.
81. Barren JA, Bresnick M, Crocker A, et al. RP431, a potential thrombus imaging agent. J Nucl Med 1995;36:16P.
82. tm for imaging arterial thrombus: preclinical studies in a canine model of intra-artenal thrombus. J Nucl Med 1996;37:152p.
83. Vallabhajosula S, Weinberger J, Machac J, et al. Technetium-99m P280, activated platelet-specific techtide: Phase 11 clinical studies in patients with carotid atherosclerosis. J Nucl Med 1996;37:272p.
84. 18F-2-deoxyglucose for the measurement of myocardial glucose metabolism. J Nucl Med 1978;19:1311-1319.
85. Strauss LG, Conti PS. The applications of PET in clinical oncology. J Nucl Med 1991;32:623-648.
86. Kubota R, Kubota K, Yamada S, et. al. Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake. J Nucl Med 1994;35:104-112.
87. Vallabhajosula, J Machac, K Knesaurek, J, et al. Imaging atherosclerotic macrophage density by positron emission tomography using F-18-fluorodeoxyglucose (FDG). J Nucl Med 1996;37:38p.